THEMISMED — Themis Medicare Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹20.02bn
- IN₹20.74bn
- IN₹3.82bn
Annual cashflow statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 269 | 413 | 953 | 725 | 534 |
| Depreciation | |||||
| Non-Cash Items | 10.6 | -8.83 | -97.2 | -105 | -137 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -359 | 79.8 | -606 | -565 | -299 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.28 | 570 | 344 | 161 | 221 |
| Capital Expenditures | -58.1 | -180 | -206 | -287 | -184 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.4 | 23.9 | 50.4 | 47.9 | 24.7 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -54.7 | -157 | -156 | -240 | -159 |
| Financing Cash Flow Items | -111 | -110 | -65.4 | -79.9 | -76.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 67.2 | -256 | -175 | 1.36 | -87.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.9 | 157 | 12.6 | -77.3 | -26.2 |